An Industry Perspective on Risks and Mitigation strategies Associated with Post Conduct Phase of Clinical Trial.

CONCLUSION: Sponsors must act proactively to ensure a systematic approach to conduct various post conduct trial activities and the plans to mitigate the risks that could affect the quality and outcome of the clinical trial. Others/ Future perspective: A close coordination with all stakeholders for timely anticipation of risks and execution of mitigation strategies are required for successful CT outcome.
PMID: 31622223 [PubMed - as supplied by publisher]

Source: Reviews on Recent Clinical Trials - October 14, 2019 Category: Cancer & Oncology Authors: Bhagat S, Kapatkar VK, Mane A, Pinto C, Parikh D, Mittal G, Jain R Tags: Rev Recent Clin Trials Source Type: research